Lantheus Holdings, Inc. (LNTH) Scorecard
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
56/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 3 wins, 9 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
WinLNTH / S&P 46.26% / 15.20% |
LoseLNTH / S&P 2.35% / 15.00% |
LoseLNTH / S&P 10.43% / 50.40% |
| 2026-Q11/3 |
WinLNTH / S&P 13.97% / -4.33% |
LoseLNTH / S&P 0.62% / 11.30% |
LoseLNTH / S&P 18.29% / 27.70% |
| 2025-Q41/3 |
WinLNTH / S&P 29.75% / 2.65% |
LoseLNTH / S&P 0.50% / 9.00% |
LoseLNTH / S&P -22.76% / 13.40% |
| 2025-Q30/3 |
LoseLNTH / S&P -37.34% / 8.12% |
LoseLNTH / S&P 1.95% / 4.61% |
LoseLNTH / S&P -60.73% / 13.45% |
| 2025-Q21/3 |
LoseLNTH / S&P -16.13% / 10.94% |
WinLNTH / S&P 5.75% / 4.83% |
LoseLNTH / S&P -38.69% / 10.63% |
| 2025-Q12/3 |
WinLNTH / S&P 9.10% / -4.27% |
WinLNTH / S&P 12.53% / 4.98% |
LoseLNTH / S&P -46.56% / 10.57% |
| 2024-Q41/3 |
LoseLNTH / S&P -18.49% / 2.41% |
WinLNTH / S&P 18.32% / 5.25% |
LoseLNTH / S&P -6.25% / 6.15% |
| 2024-Q33/3 |
WinLNTH / S&P 36.69% / 5.89% |
WinLNTH / S&P 24.15% / 5.89% |
WinLNTH / S&P 303.36% / 6.11% |
| 2024-Q23/3 |
WinLNTH / S&P 29.00% / 4.28% |
WinLNTH / S&P 27.83% / 5.38% |
WinLNTH / S&P 1197.87% / 5.12% |
| 2024-Q11/3 |
LoseLNTH / S&P 0.39% / 10.56% |
WinLNTH / S&P 32.98% / 5.71% |
LoseLNTH / S&P -2720.00% / 5.59% |
| 2023-Q42/3 |
LoseLNTH / S&P -10.77% / 11.69% |
WinLNTH / S&P 38.65% / 6.81% |
WinLNTH / S&P 1060.00% / 7.78% |
| 2023-Q32/3 |
LoseLNTH / S&P -17.21% / -3.27% |
WinLNTH / S&P 50.43% / 7.52% |
WinLNTH / S&P 0.68% / -5.03% |
| 2023-Q22/3 |
LoseLNTH / S&P 1.65% / 8.74% |
WinLNTH / S&P 69.36% / 9.50% |
WinLNTH / S&P 11.90% / -8.57% |
| 2023-Q12/3 |
WinLNTH / S&P 62.01% / 7.50% |
WinLNTH / S&P 89.62% / 10.77% |
LoseLNTH / S&P -56.90% / -15.69% |
| 2022-Q41/3 |
LoseLNTH / S&P -27.54% / 7.56% |
WinLNTH / S&P 119.91% / 11.88% |
LoseLNTH / S&P -137.74% / -17.99% |
| 2022-Q32/3 |
WinLNTH / S&P 6.51% / -4.88% |
WinLNTH / S&P 105.61% / 13.47% |
LoseLNTH / S&P -390.20% / -1.41% |
| 2022-Q22/3 |
WinLNTH / S&P 19.38% / -16.10% |
WinLNTH / S&P 76.53% / 13.71% |
LoseLNTH / S&P -202.44% / 11.04% |
| 2022-Q13/3 |
WinLNTH / S&P 91.45% / -4.60% |
WinLNTH / S&P 58.72% / 15.97% |
WinLNTH / S&P 222.22% / 42.23% |
| 2021-Q43/3 |
WinLNTH / S&P 12.50% / 11.03% |
WinLNTH / S&P 25.28% / 15.00% |
WinLNTH / S&P 360.87% / 96.40% |
| 2021-Q31/3 |
LoseLNTH / S&P -7.09% / 0.58% |
WinLNTH / S&P 16.50% / 10.77% |
LoseLNTH / S&P -737.50% / 69.42% |
| 2021-Q22/3 |
WinLNTH / S&P 29.34% / 8.55% |
WinLNTH / S&P 13.39% / 6.58% |
LoseLNTH / S&P -236.67% / 51.81% |
| 2021-Q11/3 |
WinLNTH / S&P 58.41% / 6.17% |
LoseLNTH / S&P -2.93% / -1.06% |
LoseLNTH / S&P -129.03% / 7.39% |
| 2020-Q41/3 |
LoseLNTH / S&P 6.47% / 12.15% |
WinLNTH / S&P -2.28% / -3.72% |
LoseLNTH / S&P -129.11% / -33.42% |
| 2020-Q30/3 |
LoseLNTH / S&P -11.40% / 8.93% |
LoseLNTH / S&P -2.81% / -2.04% |
LoseLNTH / S&P -90.80% / -27.10% |
| 2020-Q20/3 |
LoseLNTH / S&P 12.07% / 20.54% |
LoseLNTH / S&P -4.48% / -0.46% |
LoseLNTH / S&P -69.70% / -27.11% |
| 2020-Q10/3 |
LoseLNTH / S&P -37.79% / -19.60% |
LoseLNTH / S&P 1.23% / 3.47% |
LoseLNTH / S&P -42.59% / -14.75% |
| 2019-Q40/3 |
LoseLNTH / S&P -18.17% / 9.07% |
LoseLNTH / S&P 1.15% / 5.36% |
LoseLNTH / S&P -24.04% / 2.99% |
| 2019-Q30/3 |
LoseLNTH / S&P -11.43% / 1.70% |
LoseLNTH / S&P 1.75% / 5.02% |
LoseLNTH / S&P -72.81% / 0.21% |
| 2019-Q21/3 |
WinLNTH / S&P 15.60% / 4.30% |
LoseLNTH / S&P 5.47% / 6.64% |
LoseLNTH / S&P -68.87% / 8.65% |
| 2019-Q11/3 |
WinLNTH / S&P 56.42% / 13.65% |
LoseLNTH / S&P 4.39% / 8.12% |
LoseLNTH / S&P -67.07% / 14.29% |
| 2018-Q41/3 |
WinLNTH / S&P 4.68% / -13.52% |
LoseLNTH / S&P 3.62% / 9.05% |
LoseLNTH / S&P -67.30% / 18.23% |
| 2018-Q31/3 |
LoseLNTH / S&P 2.75% / 7.71% |
LoseLNTH / S&P 4.27% / 10.21% |
WinLNTH / S&P 305.06% / 19.06% |
| 2018-Q21/3 |
LoseLNTH / S&P -8.49% / 3.43% |
LoseLNTH / S&P 3.71% / 9.03% |
WinLNTH / S&P 354.29% / 14.46% |
| 2018-Q12/3 |
LoseLNTH / S&P -22.25% / -0.76% |
WinLNTH / S&P 8.45% / 7.68% |
WinLNTH / S&P 455.93% / 12.46% |
| 2017-Q43/3 |
WinLNTH / S&P 14.89% / 6.64% |
WinLNTH / S&P 9.78% / 7.03% |
WinLNTH / S&P 287.80% / 13.82% |
| 2017-Q31/3 |
LoseLNTH / S&P 0.85% / 4.48% |
WinLNTH / S&P 8.63% / 5.68% |
LoseLNTH / S&P -15.96% / 17.57% |
| 2017-Q22/3 |
WinLNTH / S&P 41.20% / 3.09% |
WinLNTH / S&P 5.95% / 4.83% |
LoseLNTH / S&P -29.29% / 17.74% |
| 2017-Q12/3 |
WinLNTH / S&P 45.35% / 6.07% |
WinLNTH / S&P 3.94% / 3.67% |
LoseLNTH / S&P LNTH unavailable / 13.32% |
| 2016-Q42/3 |
WinLNTH / S&P 3.86% / 3.82% |
WinLNTH / S&P 2.86% / 2.09% |
LoseLNTH / S&P LNTH unavailable / 7.05% |
| 2016-Q31/3 |
WinLNTH / S&P 125.61% / 3.85% |
LoseLNTH / S&P -0.18% / 0.20% |
LoseLNTH / S&P LNTH unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | LNTH total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 83.01% | 20.78% |
| Annualized return | 83.01% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | LNTH total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 275.45% | 83.14% |
| Annualized return | 30.29% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | LNTH total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 957.58% | 319.30% |
| Annualized return | 26.60% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |